|
End-of-day quote
New Zealand S.E.
06/10/2026
|
5-day change | 1st Jan Change | ||
| 4.330 NZD | +0.70% |
|
-0.46% | +28.11% |
| 07:12am | ASX Preview: Australian Shares to Rise as Oil Prices Fall; Tower Lifts Fiscal 2026 Profit Guidance | MT |
| 10-06 | AFT Pharmaceuticals on Track for Fiscal 2027 Revenue, Profit Targets | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AFT Stock
- Consensus AFT Pharmaceuticals Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
